We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.52B
1-Year Est. Return 36.54%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+36.54%
3 Year Est. Return
+184.84%
5 Year Est. Return
+166.78%
10 Year Est. Return
+454.52%
AUM
$931M
AUM Growth
+$6.44M
Cap. Flow
-$79M
Cap. Flow %
-8.48%
Top 10 Hldgs %
45.92%
Holding
243
New
87
Increased
6
Reduced
6
Closed
89

Top Buys

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$39.2M
2
OTEX icon
Open Text
OTEX
+$30M
3
CODI icon
Compass Diversified
CODI
+$27.6M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$18.2M
5
CGON icon
CG Oncology
CGON
+$13.4M

Top Sells

Rank Stock Value
1
LBRDK
Liberty Broadband Class C
LBRDK
+$47.6M
2
LLYVK icon
Liberty Live Group Series C
LLYVK
+$43.3M
3
MBC icon
MasterBrand
MBC
+$28.3M
4
WS icon
Worthington Steel
WS
+$24M
5
VAL icon
Valaris
VAL
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 17.65%
2 Healthcare 15.88%
3 Consumer Discretionary 10.74%
4 Materials 10.42%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIO icon
1
Rio Tinto
RIO
$169B
$58.3M 6.25%
998,661
– –
WDC icon
2
Western Digital
WDC
$174B
$52.7M 5.66%
+824,256
New +$39.2M
ENVA icon
3
Enova International
ENVA
$5.58B
$46.3M 4.97%
415,160
– –
LAUR icon
4
Laureate Education
LAUR
$4.96B
$45.1M 4.85%
1,930,871
– –
TIGO icon
5
Millicom
TIGO
$15.7B
$40.4M 4.34%
1,079,249
– –
ATMU icon
6
Atmus Filtration Technologies
ATMU
$3.79B
$40M 4.3%
1,099,631
– –
AER icon
7
AerCap
AER
$22.2B
$39.9M 4.28%
340,904
– –
ECVT icon
8
Ecovyst
ECVT
$1.12B
$37.4M 4.01%
4,538,410
– –
MRP
9
Millrose Properties Inc
MRP
$5.06B
$34M 3.65%
1,191,659
– –
INDV icon
10
Indivior Pharmaceuticals
INDV
$4.1B
$33.5M 3.6%
2,272,668
+1,559,870
+219% +$18.2M
SGI
11
Somnigroup International
SGI
$14.4B
$32.4M 3.48%
475,963
+12,088
+3% +$761K
TEVA icon
12
Teva Pharmaceuticals
TEVA
$42.9B
$32.4M 3.48%
1,932,427
– –
OTEX icon
13
Open Text
OTEX
$5.47B
$32.2M 3.46%
+1,102,346
New +$30M
IJR icon
14
iShares Core S&P Small-Cap ETF
IJR
$108B
$25.5M 2.73%
232,878
+9,578
+4% +$990K
MREO
15
Mereo BioPharma
MREO
$38.7M
$23.4M 2.51%
8,636,485
– –
PTGX icon
16
Protagonist Therapeutics
PTGX
$9.39B
$21.9M 2.35%
395,383
– –
UBS icon
17
UBS Group
UBS
$168B
$17.8M 1.92%
527,637
– –
NWSA icon
18
News Corp Class A
NWSA
$15.9B
$15.7M 1.69%
529,204
– –
CODI icon
19
Compass Diversified
CODI
$844M
$15.6M 1.67%
+2,478,276
New +$27.6M
CENTA icon
20
Central Garden & Pet Co Class A
CENTA
$2.15B
$15.4M 1.66%
493,056
– –
AUR icon
21
Aurora
AUR
$13B
$14.8M 1.58%
2,815,036
– –
CGON icon
22
CG Oncology
CGON
$6.38B
$14.4M 1.55%
+555,117
New +$13.4M
PPLI
23
People Inc
PPLI
$2.81B
$12.6M 1.36%
338,643
-74,163
-18% -$2.68M
RZLT icon
24
Rezolute
RZLT
$391M
$10.2M 1.1%
+2,297,489
New +$8.53M
RKT icon
25
Rocket Companies
RKT
$38B
$9.5M 1.02%
669,758
+537,492
+406% +$6.97M
1
2 3 4 5

Similar funds

ACM
Atika Capital Management New York $1.52B AUM 229.41% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.52B AUM 23.15% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.52B AUM 10.48% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return

Mangrove Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Mangrove Partners held 243 positions worth $931M, up 0.7% from $925M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Mangrove Partners withdrew a net $79M in Q2 2025, closing 89 positions and reducing 6 holdings. Its most notable exit was Liberty Broadband Class C, an estimated $47.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Mangrove Partners opened a new position in Western Digital worth $52.7M.

  • Mangrove Partners's largest Q2 2025 buy was Western Digital: 824,256 shares worth $52.7M.
  • Mangrove Partners added most to Indivior Pharmaceuticals in Q2 2025, an estimated $18.2M increase.
  • Mangrove Partners's biggest Q2 2025 reduction was John Hancock Premium Dividend Fund, cutting an estimated $4.34M.
  • Mangrove Partners fully exited Liberty Broadband Class C in Q2 2025, selling an estimated $47.6M.
  • Mangrove Partners's ten largest holdings make up 46% of its $931M portfolio in Q2 2025.
  • Mangrove Partners opened 87 new positions and closed 89 in Q2 2025.
  • Mangrove Partners's portfolio value rose 0.7% quarter-over-quarter to $931M.

Based on Mangrove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.